Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Maltête D[au]:

Neurostimulation for Parkinson's disease with early motor complications. Schuepbach WM et al. N Engl J Med. (2013)

Adult-onset stereotypical motor behaviors. Maltête D et al. Rev Neurol (Paris). (2016)

Primary brain calcification: an international study reporting novel variants and associated phenotypes. Ramos EM et al. Eur J Hum Genet. (2018)

Search results

Items: 1 to 50 of 108

1.

Accuracy of the robot-assisted procedure in deep brain stimulation.

Goia A, Gilard V, Lefaucheur R, Welter ML, Maltête D, Derrey S.

Int J Med Robot. 2019 Aug 10:e2032. doi: 10.1002/rcs.2032. [Epub ahead of print]

PMID:
31400032
2.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Aug;65:217-223. doi: 10.1016/j.parkreldis.2019.05.023. Epub 2019 Jun 18.

PMID:
31257096
3.

Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?

Mariani LL, Doulazmi M, Chaigneau V, Brefel-Courbon C, Carrière N, Danaila T, Defebvre L, Defer G, Dellapina E, Doé de Maindreville A, Geny C, Maltête D, Meissner WG, Rascol O, Thobois S, Torny F, Tranchant C, Vidailhet M, Corvol JC, Degos B; NS-Park/F-CRIN Network study group.

Parkinsonism Relat Disord. 2019 Jul;64:226-234. doi: 10.1016/j.parkreldis.2019.04.012. Epub 2019 Apr 25.

PMID:
31047798
4.

Characterization of XPR1/SLC53A1 variants located outside of the SPX domain in patients with primary familial brain calcification.

López-Sánchez U, Nicolas G, Richard AC, Maltête D, Charif M, Ayrignac X, Goizet C, Touhami J, Labesse G, Battini JL, Sitbon M.

Sci Rep. 2019 May 1;9(1):6776. doi: 10.1038/s41598-019-43255-x.

5.

Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype.

Grangeon L, Wallon D, Charbonnier C, Quenez O, Richard AC, Rousseau S, Budowski C, Lebouvier T, Corbille AG, Vidailhet M, Méneret A, Roze E, Anheim M, Tranchant C, Favrole P, Antoine JC, Defebvre L, Ayrignac X, Labauge P, Pariente J, Clanet M, Maltête D, Rovelet-Lecrux A, Boland A, Deleuze JF; French PFBC study group , Frebourg T, Hannequin D, Campion D, Nicolas G.

Brain. 2019 Jun 1;142(6):1573-1586. doi: 10.1093/brain/awz095.

PMID:
31009047
6.

Does Bilateral Deep Brain Stimulation of the Subthalamic Nucleus Modify Ano-Rectal Motility in Parkinson's Disease? Results of a Randomized Cross-Over Study.

Gourcerol G, Maltete D, Chastan N, Welter ML, Leroi AM, Derrey S.

Neuromodulation. 2019 Jun;22(4):478-483. doi: 10.1111/ner.12947. Epub 2019 Mar 25.

PMID:
30908813
7.

White matter tracts lesions and decline of verbal fluency after deep brain stimulation in Parkinson's disease.

Costentin G, Derrey S, Gérardin E, Cruypeninck Y, Pressat-Laffouilhere T, Anouar Y, Wallon D, Le Goff F, Welter ML, Maltête D.

Hum Brain Mapp. 2019 Jun 15;40(9):2561-2570. doi: 10.1002/hbm.24544. Epub 2019 Feb 18.

PMID:
30779251
8.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

9.

Acute hemichorea revealing atrial flutter.

Hebant B, Guyant-Marechal L, Maltête D, Lefaucheur R.

J Postgrad Med. 2018 Dec 27. doi: 10.4103/jpgm.JPGM_448_18. [Epub ahead of print]

10.

Suggestive association between OPRM1 and impulse control disorders in Parkinson's disease.

Cormier-Dequaire F, Bekadar S, Anheim M, Lebbah S, Pelissolo A, Krack P, Lacomblez L, Lhommée E, Castrioto A, Azulay JP, Defebvre L, Kreisler A, Durif F, Marques-Raquel A, Brefel-Courbon C, Grabli D, Roze E, Llorca PM, Ory-Magne F, Benatru I, Ansquer S, Maltête D, Tir M, Krystkowiak P, Tranchant C, Lagha-Boukbiza O, Lebrun-Vignes B, Mangone G, Vidailhet M, Charbonnier-Beaupel F, Rascol O, Lesage S, Brice A, Tezenas du Montcel S, Corvol JC; BADGE-PD study group.

Mov Disord. 2018 Dec;33(12):1878-1886. doi: 10.1002/mds.27519. Epub 2018 Nov 16.

PMID:
30444952
11.

Pathological Laughter as a Symptom of Middle Cerebral Artery Stroke.

Özel G, Maltête D, Lefaucheur R.

J Emerg Med. 2018 Nov;55(5):707-709. doi: 10.1016/j.jemermed.2018.07.020. Epub 2018 Sep 22.

PMID:
30249344
12.

In-hospital delays to stroke thrombolysis: Out of hours versus regular hours and reduction in treatment times through the creation of a 24/7 mobile thrombolysis team.

Hebant B, Triquenot-Bagan A, Guegan-Massardier E, Ozkul-Wermester O, Maltête D.

J Neurol Sci. 2018 Sep 15;392:46-50. doi: 10.1016/j.jns.2018.07.009. Epub 2018 Jul 11.

PMID:
30097154
13.

Hereditary neuropathy with liability to pressure palsies mimicking chronic inflammatory demyelinating polyneuropathy.

Özel G, Maisonobe T, Guyant-Maréchal L, Maltête D, Lefaucheur R.

Rev Neurol (Paris). 2018 Sep - Oct;174(7-8):575-577. doi: 10.1016/j.neurol.2017.11.012. Epub 2018 Jul 13. No abstract available.

PMID:
30017102
14.

Primary brain calcification: an international study reporting novel variants and associated phenotypes.

Ramos EM, Carecchio M, Lemos R, Ferreira J, Legati A, Sears RL, Hsu SC, Panteghini C, Magistrelli L, Salsano E, Esposito S, Taroni F, Richard AC, Tranchant C, Anheim M, Ayrignac X, Goizet C, Vidailhet M, Maltete D, Wallon D, Frebourg T, Pimentel L, Geschwind DH, Vanakker O, Galasko D, Fogel BL, Innes AM, Ross A, Dobyns WB, Alcantara D, O'Driscoll M, Hannequin D, Campion D; French PFBC study group, Oliveira JR, Garavaglia B, Coppola G, Nicolas G.

Eur J Hum Genet. 2018 Oct;26(10):1462-1477. doi: 10.1038/s41431-018-0185-4. Epub 2018 Jun 28.

15.

How safe are carmustine wafers?

Grangeon L, Ferracci FX, Fetter D, Maltete D, Langlois O, Gilard V.

Rev Neurol (Paris). 2018 May;174(5):346-351. doi: 10.1016/j.neurol.2017.09.011. Epub 2018 Apr 25. No abstract available.

PMID:
29703443
16.

Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial.

Lhommée E, Wojtecki L, Czernecki V, Witt K, Maier F, Tonder L, Timmermann L, Hälbig TD, Pineau F, Durif F, Witjas T, Pinsker M, Mehdorn M, Sixel-Döring F, Kupsch A, Krüger R, Elben S, Chabardès S, Thobois S, Brefel-Courbon C, Ory-Magne F, Regis JM, Maltête D, Sauvaget A, Rau J, Schnitzler A, Schüpbach M, Schade-Brittinger C, Deuschl G, Houeto JL, Krack P; EARLYSTIM study group.

Lancet Neurol. 2018 Mar;17(3):223-231. doi: 10.1016/S1474-4422(18)30035-8.

PMID:
29452685
17.

The pathophysiological mechanisms of motivational deficits in Parkinson's disease.

Chagraoui A, Boukhzar L, Thibaut F, Anouar Y, Maltête D.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:138-152. doi: 10.1016/j.pnpbp.2017.10.022. Epub 2017 Oct 31. Review.

PMID:
29097256
18.

Predictive Factors of Headache Resolution After Chiari Type 1 Malformation Surgery.

Grangeon L, Puy L, Gilard V, Hebant B, Langlois O, Derrey S, Gerardin E, Maltete D, Guegan-Massardier E, Magne N.

World Neurosurg. 2018 Feb;110:e60-e66. doi: 10.1016/j.wneu.2017.10.070. Epub 2017 Oct 21.

PMID:
29066319
19.

Indomethacin-Responsive Paroxysmal Hemicrania in an Elderly Man: An Unusual Presentation of Pituitary Apoplexy.

Grangeon L, Moscatelli L, Zanin A, Rouille A, Maltete D, Guegan-Massardier E.

Headache. 2017 Nov;57(10):1624-1626. doi: 10.1111/head.13201. Epub 2017 Oct 5. No abstract available.

PMID:
28980712
20.

Anti-epileptic drugs induce cutaneous lymphocyte-associated antigen downregulation leading to potential human herpes virus-7 reactivation in clinically asymptomatic patients.

Caillot F, Andrieu E, Houivet E, Duvert-Lehembre S, Calbo S, Sabbah B, Maltete D, Martinaud O, Le Goff F, Malekpour P, Berard M, Rogez S, Joly P, Picard D, Musette P.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e41-e43. doi: 10.1111/jdv.14493. Epub 2017 Oct 10. No abstract available.

PMID:
28758263
21.

Acute necrotic pancreatitis: A rare and not always fatal cause of central pontine myelinolysis.

Grangeon L, Salomon B, Schnell G, Maltete D, Frenoy E, Abily J.

Presse Med. 2017 Oct;46(10):968-970. doi: 10.1016/j.lpm.2017.06.011. Epub 2017 Jul 27. No abstract available.

PMID:
28757177
22.

Four Cases of Parkinson Disease Diagnosed During the Postpartum Period.

Maltête D, Grangeon L, Le Goff F, Ozel G, Fetter D, Ahtoy P, Temgoua O, Rouillé A, Lefaucheur R.

Obstet Gynecol. 2017 Jul;130(1):203-206. doi: 10.1097/AOG.0000000000002066.

PMID:
28594769
23.

Management and outcome of cerebral venous thrombosis after head trauma: A case series.

Grangeon L, Gilard V, Ozkul-Wermester O, Lefaucheur R, Curey S, Gerardin E, Derrey S, Maltete D, Magne N, Triquenot A.

Rev Neurol (Paris). 2017 Jun;173(6):411-417. doi: 10.1016/j.neurol.2017.03.025. Epub 2017 May 8.

PMID:
28495232
24.

Symptomatic cervical myelopathy due to general dystonia: Case report and review of the literature.

Gilard V, Lefaucheur R, Grangeon L, Maltête D, Perez A, Derrey S.

Rev Neurol (Paris). 2017 Jun;173(6):424-426. doi: 10.1016/j.neurol.2017.03.009. Epub 2017 Apr 12. No abstract available.

PMID:
28410743
25.

Impact of an intrahospital mobile thrombolysis team on 3-month clinical outcomes in patients benefiting from intravenous thrombolysis for acute ischemic stroke.

Hebant B, Triquenot-Bagan A, Guegan-Massardier E, Ozkul-Wermester O, Grangeon L, Maltête D.

Rev Neurol (Paris). 2017 Mar;173(3):152-158. doi: 10.1016/j.neurol.2017.02.003. Epub 2017 Mar 15.

PMID:
28314516
26.

Clavicle fracture mimicking dropped-head syndrome in a patient with multiple system atrophy.

Le Goff F, Duparc F, Lefaucheur R, Fetter D, Rouillé A, Maltête D.

Parkinsonism Relat Disord. 2017 Feb;35:98-99. doi: 10.1016/j.parkreldis.2016.11.008. Epub 2016 Nov 18. No abstract available.

PMID:
27887895
27.

Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.

Hébant B, Guillaume M, Desbordes M, Gaillon G, Maltête D, Lefaucheur R.

Rev Neurol (Paris). 2016 Dec;172(12):788-789. doi: 10.1016/j.neurol.2016.10.002. Epub 2016 Nov 9. No abstract available.

PMID:
27838092
28.

Tattooing as a Symptom of Impulse Control Disorder in a Parkinsonian Patient With Pramipexole.

Maltête D, Le Goff F, Ozel G, Lefaucheur R.

J Clin Psychopharmacol. 2016 Dec;36(6):736-737. No abstract available.

PMID:
27749676
29.

Subjective Perceived Motor Improvement after Acute Levodopa Challenge in Parkinson's Disease.

Rabel C, Le Goff F, Lefaucheur R, Ozel G, Fetter D, Rouillé A, Maltête D.

J Parkinsons Dis. 2016 Oct 19;6(4):779-785.

PMID:
27662330
30.

Leucoencephalopathy following abuse of sniffed heroin.

Lefaucheur R, Lebas A, Gérardin E, Grangeon L, Ozkul-Wermester O, Aubier-Girard C, Martinaud O, Maltête D.

J Clin Neurosci. 2017 Jan;35:70-72. doi: 10.1016/j.jocn.2016.09.023. Epub 2016 Oct 11.

PMID:
27742371
31.

Headache changes prior to aneurysmal rupture: A symptom of unruptured aneurysm?

Gilard V, Grangeon L, Guegan-Massardier E, Sallansonnet-Froment M, Maltête D, Derrey S, Proust F.

Neurochirurgie. 2016 Oct;62(5):241-244. doi: 10.1016/j.neuchi.2016.03.004. Epub 2016 Aug 12.

PMID:
27527623
32.

Adult-onset stereotypical motor behaviors.

Maltête D.

Rev Neurol (Paris). 2016 Aug - Sep;172(8-9):477-482. doi: 10.1016/j.neurol.2016.07.002. Epub 2016 Aug 3. Review.

PMID:
27498241
33.

French consensus procedure for assessing cognitive function in Parkinson's disease.

Dujardin K, Auzou N, Lhommée E, Czernecki V, Dubois B, Fradet A, Maltete D, Meyer M, Pineau F, Schmitt E, Sellal F, Tison F, Vidal T, Azulay JP, Welter ML, Corvol JC, Durif F, Rascol O; NS-Park network.

Rev Neurol (Paris). 2016 Nov;172(11):696-702. doi: 10.1016/j.neurol.2016.05.001. Epub 2016 Jun 16.

PMID:
27318613
34.

Anti-MuSK myasthenia gravis with prolonged remission.

Bouwyn JP, Magnier P, Bédat-Millet AL, Ahtoy P, Maltête D, Lefaucheur R.

Neuromuscul Disord. 2016 Jul;26(7):453-4. doi: 10.1016/j.nmd.2016.04.008. Epub 2016 Apr 8.

PMID:
27161384
35.

Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients.

Heranval A, Lefaucheur R, Fetter D, Rouillé A, Le Goff F, Maltête D.

Rev Neurol (Paris). 2016 Apr-May;172(4-5):318-23. doi: 10.1016/j.neurol.2015.11.007. Epub 2016 Apr 7.

PMID:
27063094
36.

Age Limits for Deep Brain Stimulation of Subthalamic Nuclei in Parkinson's Disease.

Bouwyn JP, Derrey S, Lefaucheur R, Fetter D, Rouille A, Le Goff F, Maltête D.

J Parkinsons Dis. 2016 Apr 2;6(2):393-400. doi: 10.3233/JPD-150742.

PMID:
27061064
37.

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.

Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc'h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group.

J Alzheimers Dis. 2016;51(3):905-13. doi: 10.3233/JAD-151111.

PMID:
26890785
38.

Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.

Bourre B, Gueudry J, Lefaucheur R, Borden A, Maltête D, Patel SS, Van Tassel SH, Gupta MP, Orlin A, Nealon NM.

Neurology. 2016 Jan 19;86(3):312-3. doi: 10.1212/WNL.0000000000002302. No abstract available.

PMID:
26783270
39.

Recurrent Bilateral Dislocation of the Temporomandibular Joint Induced by Clonazepam in a Parkinsonian Patient.

Le Goff F, Lefaucheur R, Fetter D, Rouille A, Maltête D.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):66. doi: 10.1097/WNF.0000000000000124. No abstract available.

PMID:
26757315
40.

Pre-operative obesity may influence subthalamic stimulation outcome in Parkinson's disease.

Rouillé A, Derrey S, Lefaucheur R, Borden A, Fetter D, Jan M, Maltête D.

J Neurol Sci. 2015 Dec 15;359(1-2):260-5. doi: 10.1016/j.jns.2015.11.012. Epub 2015 Nov 7.

PMID:
26671125
41.

Generalized pruritus preceding paraneoplastic neuropathy.

Hébant B, Miret N, Berthelot L, Jaafar M, Maltête D, Lefaucheur R.

J Clin Neurosci. 2016 Apr;26:156-7. doi: 10.1016/j.jocn.2015.09.015. Epub 2015 Nov 26.

PMID:
26633089
42.

Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?

Lefaucheur R, Le Goff F, Gaillon G, Triquenot-Bagan A, Maltête D.

Presse Med. 2015 Nov;44(11):1203-4. doi: 10.1016/j.lpm.2015.09.007. No abstract available.

PMID:
26433836
43.

A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.

Hotier S, Maltete D, Bourre B, Jegouzo X, Bourgeois V, Guillin O.

Gen Hosp Psychiatry. 2015 Nov-Dec;37(6):621.e1-2. doi: 10.1016/j.genhosppsych.2015.07.002. Epub 2015 Jul 14.

PMID:
26321022
44.

Subthalamic stimulation: toward a simplification of the electrophysiological procedure.

Fetter D, Derrey S, Lefaucheur R, Borden A, Wallon D, Chastan N, Maltete D.

J Neurosurg Sci. 2016 Jun;60(2):169-72. Epub 2015 Jul 24.

PMID:
26207387
45.

Impact of deep brain stimulation on pharyngo-esophageal motility: a randomized cross-over study.

Derrey S, Chastan N, Maltete D, Verin E, Dechelotte P, Lefaucheur R, Proust F, Freger P, Leroi AM, Weber J, Gourcerol G.

Neurogastroenterol Motil. 2015 Sep;27(9):1214-22. doi: 10.1111/nmo.12607. Epub 2015 Jun 5.

PMID:
26053217
46.

Stroke mimicking relapse in a patient with CLIPPERS syndrome.

Lefaucheur R, Bourre B, Ozkul-Wermester O, Maltête D, Wallon D.

Acta Neurol Belg. 2015 Dec;115(4):735-6. doi: 10.1007/s13760-015-0473-5. Epub 2015 Apr 14. No abstract available.

PMID:
25869738
47.

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group.

Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23.

48.

Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients.

Brun L, Lefaucheur R, Fetter D, Derrey S, Borden A, Wallon D, Bourre B, Maltête D.

Clin Neurol Neurosurg. 2014 Dec;127:93-6. doi: 10.1016/j.clineuro.2014.10.006. Epub 2014 Oct 16.

PMID:
25459250
49.

Patient with perinatal brain injury dystonia treated by deep brain stimulation: Management during pregnancy.

Lefaucheur R, Derrey S, Borden A, Verspyck E, Tourrel F, Maltête D.

Rev Neurol (Paris). 2015 Jan;171(1):90-1. doi: 10.1016/j.neurol.2014.08.005. Epub 2014 Oct 14. No abstract available.

PMID:
25444172
50.

Decline in verbal fluency after subthalamic nucleus deep brain stimulation in Parkinson's disease: a microlesion effect of the electrode trajectory?

Le Goff F, Derrey S, Lefaucheur R, Borden A, Fetter D, Jan M, Wallon D, Maltête D.

J Parkinsons Dis. 2015;5(1):95-104. doi: 10.3233/JPD-140443.

PMID:
25374271

Supplemental Content

Loading ...
Support Center